Maria Manriquez, MD
Director, Pathway Scholars Program

Pathway Scholars Program Contact:
602-827-2443
@email

Maria Manriquez, MD

Brief Bio

Maria Manriquez, MD, a University of Arizona College of Medicine – Tucson alumni, directs and supervises activities of pre-matriculation curriculum for pipeline programs. One of the premier programs is the Pathway Scholars Program (PSP), which is a master in medical studies. Ten students are selected by the admission committee for the PSP to spend a year optimizing learning styles, leadership principles and fundamental basic sciences before beginning medical school. The students are selected as either being identified as underrepresented in medicine or committed to serving an underrepresented population in their ultimate physician practice.

Additionally, Dr Manriquez is the physician lead for the Pain and Addiction Medicine Curriculum at the UArizona College of Medicine – Phoenix; she has worked with the Department of Health Services in the development of a curriculum that educates the Undergraduate Medical Education and Graduate Medical Education learners on pain and addiction. Formal education for providers who understand and implement screening, diagnosing and treating of individuals who have substance use disorder (SUD) or who are at high risk for developing SUD is a priority for our State, the Liaison Committee on Medical Education (LCME) and the Accreditation Council for Graduate Medical Education (ACGME).

Her service commitments have included multiple leadership positions with the American College of Obstetricians and Gynecologists and as an oral examiner for the American Board of Obstetricians and Gynecologists. She is board-certified in Addiction Medicine by the American Board of Preventative Medicine.

Dr. Manriquez continues clinical practice, focusing on substance use disorders in pregnancy and parenting women. Her research and advocacy focus is aimed at investigating innovations in prenatal care models addressing maternal morbidity and mortality, preterm delivery rate and substance use disorders in pregnancy.